Drawing for CELVIVO

USPTO serial 79298172

CELVIVO

Reviewed by CopyMark Law Group

Reg. 6881796Status 700Registered
Filing date
Status date
Registration date
Oct 25, 2022
Examiner
BETTS, MARCYA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CELVIVO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for use in industry and science; media and ingredients in the nature of Minimum Essential Medium, Dulbecco's Modified Eagle Medium, RPMI 1640 media recipe, F-12 Media, plant tissue culture growth medium, B5 medium, Nitsch and Nitsch medium, Yeast nitrogen base medium, Yeast Extract-Peptone-Dextrose media, Tryptic Soy Broth, Eosin methylene blue agar for cell cultures for use in non-medical research laboratories; cultures of cell media for laboratory use and scientific and research use, not for medical or veterinary use; biological preparations for use in cell cultures other than for medical or veterinary useACTIVE
009Automated cell culture incubators for eukaryotic, prokaryotic and archaeal cells for laboratory use incorporating recorded remote monitoring and control software for cell culture apparatus for laboratory or research use; bioreactor for cell culturing; disposable plastic flasks and bioreactors for cell culture; cell culture apparatus for laboratory use, namely, cell culture incubators for eukaryotic, prokaryotic and archaeal cells, cell culture dishes and tissue culture flasks, and bioreactors for cell culturingACTIVE
010Medical apparatus for cell culture, namely cell culture incubators for eukaryotic, prokaryotic and archaeal cells for medical purposes; medical apparatus and instruments for use in cell culture, and parts and fittings therefor, namely, cell culture chambers and tissue culture flasks, and bioreactors for medical purposes; automated cell culture incubators for medical purposes incorporating recorded remote monitoring and control software for cell culture apparatus for laboratory or research use, being medical apparatus; cell culture instruments for medical use, namely, cell culture incubators for eukaryotic, prokaryotic and archaeal cells, cell culture chambers and tissue culture flasks, bioreactors for cell culturing, all for medical purposes; cell growth systems comprised of cell culture chambers and tissue culture flasks and bioreactors for medical purposes; incubators for medical purposes; apparatus for cell culture for medical use, namely, cell and tissue culture chambersACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 5, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED
Sep 7, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED
Mar 6, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Feb 10, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB
Feb 9, 2023FIMPFINAL DISPOSITION PROCESSED
Jan 25, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 25, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 25, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 9, 2022GPNXNOTIFICATION PROCESSED BY IB
Aug 9, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 9, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 20, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 20, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 20, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 7, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2022XAECEXAMINER'S AMENDMENT ENTERED
Jul 6, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 6, 2022GNEAEXAMINERS AMENDMENT E-MAILED
Jul 6, 2022CNEAEXAMINERS AMENDMENT -WRITTEN
May 9, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 7, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 25, 2022GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Apr 25, 2022GNCFCONTINUATION OF FINAL REFUSAL E-MAILED
Apr 25, 2022CNCFACTION CONTINUING A FINAL - COMPLETED
Apr 20, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 20, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 30, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 29, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 29, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 7, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Oct 7, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 7, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 7, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 6, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 1, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 1, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 1, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 5, 2021RFNTREFUSAL PROCESSED BY IB
Mar 14, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 13, 2021RFRRREFUSAL PROCESSED BY MPU
Mar 9, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 8, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2021DOCKASSIGNED TO EXAMINER
Nov 24, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Nov 20, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 19, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance